We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PRTA market cap is 743.64M. The company's latest EPS is USD -2.7324 and P/E is -5.07.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 84.87M | 316k | 50k | 132.01M | 970k |
| Operating Income | 10.06M | -47.96M | -81.53M | 58.38M | -66.71M |
| Net Income | 21.91M | -67.48M | -72.24M | 66.89M | -59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 814k | 853k | 200.58M | 53.91M | 91.37M |
| Operating Income | -85.76M | -112.73M | 71.98M | -131.56M | -191.04M |
| Net Income | -77.68M | -111.14M | 66.98M | -116.95M | -147.03M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 746.92M | 696.38M | 623.19M | 645.57M | 595.25M |
| Total Liabilities | 129.69M | 135.02M | 120.8M | 63.65M | 60.89M |
| Total Equity | 617.23M | 561.37M | 502.4M | 581.92M | 534.36M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 419.27M | 332.98M | 609.37M | 758.04M | 696.38M |
| Total Liabilities | 146.35M | 148.97M | 143.32M | 135.99M | 135.02M |
| Total Equity | 272.92M | 184.01M | 466.04M | 622.04M | 561.37M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -82.87M | N/A | -73.05M | -57.09M | -102.28M |
| Investing | -1.26M | N/A | -103k | -246k | -255k |
| Financing | 44.62M | N/A | 836k | 1.28M | 1.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -52.97M | -80.36M | 92.61M | -108.82M | -133.91M |
| Investing | -547k | -196k | -575k | -464k | -2.77M |
| Financing | 228k | 215k | 190.33M | 241.46M | 45.1M |
| Market Cap | 743.64M |
| Price to Earnings Ratio | -5.07 |
| Price to Sales Ratio | 8.15 |
| Price to Cash Ratio | 1.2 |
| Price to Book Ratio | 1.33 |
| Dividend Yield | - |
| Shares Outstanding | 53.81M |
| Average Volume (1 week) | 255.96k |
| Average Volume (1 Month) | 321.22k |
| 52 Week Change | -51.96% |
| 52 Week High | 31.03 |
| 52 Week Low | 11.70 |
| Spread (Intraday) | 2.17 (14.3%) |
| Company Name | Prothena Corporation PLC |
| Address |
77 sir john rogerson’s quay dublin D02 VK60 |
| Website | https://www.prothena.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
